The Newburger-Bellinger Cardiac Neurodevelopmental Award was established in 2013 by the Cardiac Neurodevelopmental Outcome Collaborative to honor Jane Newburger and David Bellinger, pioneers in research designed to understand and improve neurodevelopmental outcomes for children with heart disease. The award is presented annually during the Scientific Sessions of the Cardiac Neurodevelopmental Outcome Collaborative.
Newburger-Bellinger Cardiac Neurodevelopmental Award NOMINATIONS ACCEPTED between April 15 and June 15, 2021.
Criteria for nomination: A cardiologist, surgeon, anesthesiologist, neurologist, developmental pediatrician, geneticist, psychologist, nurse, PhD researcher, or other neurodevelopmental professional who has made significant contributions to clinical care, research knowledge, teaching or community advocacy leading to improvements in the neurodevelopmental outcomes of children with heart disease. Please forward this page to other colleagues who may be interested. Membership in CNOC is not a factor.
Submit a letter of support that details the nominee’s significant contributions to Anjali Sadhwani PhD, CNOC Secretary. All letters of nomination will be reviewed by the Steering Committee, and all nominees notified by August 6. The selected award recipient will deliver a keynote address during CNOC’s 10th Annual Scientific Sessions, November 17-19, 2021 in virtual format.
2020 Recipient – Caren Goldberg MD MS
Caren Goldberg is a professor of pediatric cardiology at the University of Michigan. She serves as the medical director for the Cardiac Neurodevelopmental Follow-up program and the co-director of the Michigan Congenital Heart Outcomes Research and Discovery (MCHORD) for the University of Michigan Congenital Heart Center. She serves as one of the principal investigators at the University of Michigan for the work of the NHLBI-funded Pediatric Heart Network. She was part of the founding steering committee of CNOC and has served as a co-chair over the past two years. Her research interests are focused on methods of improving long-term outcomes, including neurodevelopmental and quality of life outcomes, for children with congenital heart disease. She is extremely enthusiastic about the growth of collaboration in our field and the progress of the Cardiac Neurodevelopmental Outcome Collaborative as this will enable us to more quickly answer questions, understand best practices to optimize neurodevelopmental outcomes and advance care for children with congenital heart disease.